BACKGROUND: Survival data from hospital-based or clinical trial studies of patients with chronic heart failure (CHF) do not represent survival in community-based settings. AIMS: To determine the incidence of CHF and the associated long-term survival in a community-based sample aged > or = 57 years and to assess the mortality risk associated with sex and age. METHODS: This study was part of the Groningen Longitudinal Aging Study. RESULTS: Annual incidence of CHF per 1000 ranged from 2.5 in middle aged adults (57-60 years) up to 22.4 in older females (> or = 80 years) and 28.2 in older males (> or = 80 years). The 1, 2, 5 and 7-year survival rates were 74%, 65%, 45%, 32% for patients with CHF, compared to 97%, 94%, 80% and 70% in a matched reference group without CHF. Higher age (> or = 76 years) was a risk factor for mortality (OR = 2.1) and male sex was a risk factor in those aged < or = 75 years (OR = 1.9) but not for older patients. CONCLUSION: Long-term survival rates for patients with CHF in the community were worse than the known survival rates from clinical trials. There is a need for studies describing the care of patients with CHF in the community, including the type of care, the provider, the quality of care and the outcome.
BACKGROUND: Survival data from hospital-based or clinical trial studies of patients with chronic heart failure (CHF) do not represent survival in community-based settings. AIMS: To determine the incidence of CHF and the associated long-term survival in a community-based sample aged > or = 57 years and to assess the mortality risk associated with sex and age. METHODS: This study was part of the Groningen Longitudinal Aging Study. RESULTS: Annual incidence of CHF per 1000 ranged from 2.5 in middle aged adults (57-60 years) up to 22.4 in older females (> or = 80 years) and 28.2 in older males (> or = 80 years). The 1, 2, 5 and 7-year survival rates were 74%, 65%, 45%, 32% for patients with CHF, compared to 97%, 94%, 80% and 70% in a matched reference group without CHF. Higher age (> or = 76 years) was a risk factor for mortality (OR = 2.1) and male sex was a risk factor in those aged < or = 75 years (OR = 1.9) but not for older patients. CONCLUSION: Long-term survival rates for patients with CHF in the community were worse than the known survival rates from clinical trials. There is a need for studies describing the care of patients with CHF in the community, including the type of care, the provider, the quality of care and the outcome.
Authors: Ricki Carroll; Jules Antigua; Darren Taichman; Harold Palevsky; Paul Forfia; Steven Kawut; Scott D Halpern Journal: Clin Trials Date: 2012-03-02 Impact factor: 2.486
Authors: Laura M G Meems; Frank P Brouwers; Michel M Joosten; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Ron T Gansevoort; Wiek H van Gilst; Pim van der Harst; Rudolf A de Boer Journal: ESC Heart Fail Date: 2016-04-26
Authors: Jia-Rong Wu; Debra K Moser; Mary Kay Rayens; Marla J De Jong; Misook L Chung; Barbara Riegel; Terry A Lennie Journal: Heart Lung Date: 2010 Nov-Dec Impact factor: 2.210
Authors: Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter Journal: Nat Rev Cardiol Date: 2015-12-10 Impact factor: 32.419
Authors: Jia-Rong Wu; George M Holmes; Darren A DeWalt; Aurelia Macabasco-O'Connell; Kirsten Bibbins-Domingo; Bernice Ruo; David W Baker; Dean Schillinger; Morris Weinberger; Kimberly A Broucksou; Brian Erman; Christine D Jones; Crystal W Cene; Michael Pignone Journal: J Gen Intern Med Date: 2013-03-12 Impact factor: 5.128
Authors: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen Journal: Clin Res Cardiol Date: 2009-07-15 Impact factor: 5.460